Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 7/18/2012 12:33:05 PM : Underperform Start Price: $4.31 CADX Score: -1.31

Watch out below !!

Featured Broker Partners


Advertisement